» Articles » PMID: 25713022

Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case-control Studies

Abstract

Background: We report the development of a cutaneous melanoma risk algorithm based upon seven factors; hair color, skin type, family history, freckling, nevus count, number of large nevi, and history of sunburn, intended to form the basis of a self-assessment Web tool for the general public.

Methods: Predicted odds of melanoma were estimated by analyzing a pooled dataset from 16 case-control studies using logistic random coefficients models. Risk categories were defined based on the distribution of the predicted odds in the controls from these studies. Imputation was used to estimate missing data in the pooled datasets. The 30th, 60th, and 90th centiles were used to distribute individuals into four risk groups for their age, sex, and geographic location. Cross-validation was used to test the robustness of the thresholds for each group by leaving out each study one by one. Performance of the model was assessed in an independent UK case-control study dataset.

Results: Cross-validation confirmed the robustness of the threshold estimates. Cases and controls were well discriminated in the independent dataset [area under the curve, 0.75; 95% confidence interval (CI), 0.73-0.78]. Twenty-nine percent of cases were in the highest risk group compared with 7% of controls, and 43% of controls were in the lowest risk group compared with 13% of cases.

Conclusion: We have identified a composite score representing an estimate of relative risk and successfully validated this score in an independent dataset.

Impact: This score may be a useful tool to inform members of the public about their melanoma risk.

Citing Articles

Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training.

Kaiser I, Pfahlberg A, Mathes S, Uter W, Diehl K, Steeb T J Clin Med. 2023; 12(5).

PMID: 36902763 PMC: 10003882. DOI: 10.3390/jcm12051976.


Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.

Kaiser I, Mathes S, Pfahlberg A, Uter W, Berking C, Heppt M Cancers (Basel). 2022; 14(12).

PMID: 35740698 PMC: 9221327. DOI: 10.3390/cancers14123033.


Genome-Wide Association Study Suggests the Variant rs7551288*A within the Gene Is Associated with Poor Overall Survival in Melanoma Patients.

Pflugfelder A, Yong X, Jagirdar K, Eigentler T, Soyer H, Sturm R Cancers (Basel). 2022; 14(10).

PMID: 35626014 PMC: 9139953. DOI: 10.3390/cancers14102410.


Reporting Quality of Studies Developing and Validating Melanoma Prediction Models: An Assessment Based on the TRIPOD Statement.

Kaiser I, Diehl K, Heppt M, Mathes S, Pfahlberg A, Steeb T Healthcare (Basel). 2022; 10(2).

PMID: 35206853 PMC: 8871554. DOI: 10.3390/healthcare10020238.


Risk Prediction Models for Melanoma: A Systematic Review on the Heterogeneity in Model Development and Validation.

Kaiser I, Pfahlberg A, Uter W, Heppt M, Veierod M, Gefeller O Int J Environ Res Public Health. 2020; 17(21).

PMID: 33126677 PMC: 7662952. DOI: 10.3390/ijerph17217919.


References
1.
Green A, Siskind V, Bain C, Alexander J . Sunburn and malignant melanoma. Br J Cancer. 1985; 51(3):393-7. PMC: 1976961. DOI: 10.1038/bjc.1985.53. View

2.
Elwood J, Gallagher R, Hill G, Pearson J . Cutaneous melanoma in relation to intermittent and constant sun exposure--the Western Canada Melanoma Study. Int J Cancer. 1985; 35(4):427-33. DOI: 10.1002/ijc.2910350403. View

3.
Bruzzi P, Green S, Byar D, Brinton L, Schairer C . Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985; 122(5):904-14. DOI: 10.1093/oxfordjournals.aje.a114174. View

4.
Holman C, Armstrong B, Heenan P . Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst. 1986; 76(3):403-14. View

5.
Swerdlow A, English J, Mackie R, ODoherty C, Hunter J, Clark J . Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed). 1986; 292(6535):1555-9. PMC: 1340558. DOI: 10.1136/bmj.292.6535.1555. View